Daily Judi: Friday, November 11, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
The American Journal of Managed Care interviews Joseph Alvarnas, M.D., vice president of government affairs and senior medical director for employer strategy at City of Hope, on the barriers some patients face participating in clinical trials.
Moderna struck a multi-million dollar deal with Nona Biosciences for access to its discovery platform. (Fierce Biotech)
As 3D printing becomes affordable and accessible, Gaurav Manchanda, of Formlabs, discusses how 3D printing may alter the medical device industry. (Medical Design and Outsourcing)
The CNS Summit 2022 will be held on November 17–20, in Boca Raton, Florida. Created as "a community of innovators and industry leaders who are not afraid to challenge the status quo," CNS was founded in 2009 to advance clinical development, focused on collaboration and innovation. Team AG Mednet will be there!
Our Culture
“We are small enough that we are nimble, so we can prioritize quickly, yet also of significant size that we allocate resources where needed. We truly do a lot. This is my dream job. Judi allows me to have a bigger impact. And we do great work.”
–Jess, Program Manager
About Judi
Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.
